SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amidst reports of potential federal marijuana rescheduling, sparking excitement around relaxed restrictions. Community discussions revolve around short squeeze potential and comparisons to other cannabis stocks. Investors are closely watching for further developments, with some expressing skepticism about the long-term impact.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending after earnings, with a mixed community sentiment as the stock experiences a sharp sell-off despite strong results and raised guidance, leading to speculation of manipulation and an AI bubble. Discussions revolve around the potential reasons for the decline, including profit-taking, margin concerns, and the overall market rotation out of tech. Despite the negative price action, many analysts have raised their price targets, fueling debate on whether this is a buying opportunity or a sign of further downside.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as investors discuss the potential for cannabis rescheduling, fueled by speculation around upcoming executive action and a Supreme Court review. Community members are weighing the implications of potential catalysts, with some anticipating a significant sector-wide breakout while others caution against hype-driven rallies. Discussion centers on the impact of rescheduling on US cannabis companies and strategies for trading sector momentum.

The GEO Group, Inc. engages in the design, financing, development, and support services for secure facilities, processing centers, and community re-entry facilities. It operates through the following segments: U.S. Secure, Electronic Monitoring and Supervision, Reentry, and International Services. The U.S. Secure Services segment encompasses the United States-based public-private partnership corrections and detention business. The Electronic Monitoring and Supervision Services segment conducts its services in the U.S. The Reentry Services Segment consists of various community-based and reentry services. The International Services segment consists of public-private partnership secure services operations in Australia and South Africa. The company was founded by George C. Zoley in 1984 and is headquartered in Boca Raton, FL.

Geo Group, Inc.

GEO Group is trending amid discussions around immigration policy and potential impacts on the private prison sector, with some arguing about ethical concerns around profiting from incarceration. The community is also focused on ICE contracts and the company's financial outlook, specifically regarding potential gains, losses, and potential stock buybacks. GEO's stock performance and future prospects are debated, with some bullish and others expressing concerns about the company's management and the influence of political factors.

SU Group Holdings Ltd. engages in the provision of security-related engineering services, and security guarding and screening services. It operates through the Security-Related Engineering Services and Security Guarding and Screening Services segments. The company was founded by Ming Chan in 1998 and is headquartered in Hong Kong.

SU Group Holdings Ltd. - Ordinary Shares - Class A

SU Group Holdings Ltd

SUGP is trending as traders discuss its low float and potential for a significant breakout, drawing comparisons to other Hong Kong stocks like $SMX and $OCG. Community members highlight the possibility of a short squeeze and a golden cross setup, anticipating a run towards higher price levels. Traders are closely watching the stock's movement above the $6 and $8 levels as potential catalysts for further upward momentum.

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

Argo Blockchain Plc - ADR

Argo Blockchain Plc

Argo Blockchain is trending due to discussions around its reverse stock split and London Stock Exchange delisting, with the community debating potential impacts. Some traders anticipate a rebound and short squeeze given the low float post-split, while others express skepticism about the company's financial health and potential for further dilution. Overall, the conversation reflects a mix of speculative hope and concern amidst restructuring efforts.

RYTHM, Inc. engages in the development of hardware and software solutions for indoor agriculture. The company was founded on June 6, 2016 and is headquartered in Rolling Meadows, IL.

RYTHM Inc.

RYTHM Inc. is trending amid community discussions about potential catalysts from its pipeline and high trading volume. Some traders are debating the offering's risk and watching for short covering, while others are focused on technical analysis and potential for a significant price move. Active discussions and user disputes are contributing to the stock's visibility.

Aurora Cannabis, Inc. engages in the production, distribution, and sale of cannabis and cannabis-derivative products. It operates through the Cannabis and Plant Propagation segments. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

Aurora Cannabis is trending as the cannabis sector reacts to potential federal policy changes, particularly around rescheduling. Community discussions revolve around the perceived undervaluation of ACB, its international exposure, and whether it's lagging behind sector peers. Some traders speculate on short squeezes, while others caution against over-optimism, citing historical patterns of sector volatility and policy-related "pumps and dumps".

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending as investors debate the impact of delayed data center projects and increased capital expenditures on its debt load and AI initiatives; the community is closely watching for a potential bounce or further decline, analyzing technical indicators and management's response to negative news. Some traders view the dip as a buying opportunity, while others remain cautious about the company's financial strategy and competitive positioning in the cloud and AI market. Oracle's fluctuating stock price has sparked discussion about the broader health of the AI sector, with some suggesting it may be a sign of an overhyped market.

Wealthfront integrates investing and saving products to help young professionals build long-term wealth in any market condition. Through the power of software, the company delivers high-yield saving, diversified investing, and low-cost loans to help both sophisticated and new investors learn, lower costs, and grow wealth. Wealthfront is one of the highest rated financial apps in the Apple App Store and has been named Best Automated Investment App, Best Overall Robo-Advisor, and Best Robo-Advisor for Goal Planning by Investopedia (2022), Best Cash Management Account and Best Investing App by Bankrate (2023), Best Robo-Advisor for Portfolio Options by NerdWallet (2023), and Best Robo-Advisor for DIY Financial Planning by Forbes (2023). The company currently oversees more than $30 billion for over 500,000 clients in the US.

Wealthfront Corp.

Wealthfront ($WLTH) is trending following its IPO, with the community closely watching its debut and discussing its potential. The company's focus on millennial and Gen Z clients, along with its automated wealth management platform, are key talking points. Some are comparing it to other recent IPOs and anticipating a significant spike.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Healthcare Stocks to Buy in India in 2025

The best healthcare stocks to buy in India in 2025 include Acuataas Chemicals, Neuland Labs, and Sun Pharma, top performers in India’s healthcare sector.

Indian equity markets ended lower on Monday, dragged by selling in technology after the weak earnings performance in TCS last week. Investors will be eyeing HCL Technology earnings fineprint due today.&nbsp;On Monday, the Sensex closed 247 points lower at 82,253, while the&nbsp;<a href="https://stocktwits.com/symbol/NIFTY50.NSE">Nifty 50</a> ended 67 points lower at 25,082. Broader markets outperformed, with the Midcap index rising 0.7% and the Smallcap indices gaining over 1%.&nbsp;The retail investor sentiment surrounding the Nifty 50 remained ‘bearish’ on Stocktwits.<figure class="image"><img style="aspect-ratio:808/97;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_14_160031_png_aa43e471dc.webp" alt="Screenshot 2025-07-14 160031.png" width="808" height="97"><figcaption>Nifty sentiment and message volume on July 14 as of 4:00 pm IST. | source: Stocktwits</figcaption></figure>Sectorally, IT was the biggest loser, ending over 1% lower. On the other hand, media, real estate, pharmaceuticals, and consumer durables saw significant gains.&nbsp;<a href="https://stocktwits.com/symbol/OLAELEC.NSE">Ola Electric shares</a> extend gains to 16% despite reporting a wider loss in Q1 as its auto business made an operating profit in June. The company also shared aggressive guidance for FY26.&nbsp;However, analyst Mayank Singh Chandel noted that the stock is in a clear downtrend on the charts and does not appear strong fundamentally either. He advised staying away from this stock for now and waiting for signs of improvement.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/620825557</stembedurl><a href="https://stocktwits.com/symbol/VIPIND.NSE">VIP</a> ended 5% higher even after promoters sold a 32% stake in the company to multiple buyers.&nbsp;Strong volume movers include Eternal, Glenmark, JP Power, and Vishal Mega Mart.<a href="https://stocktwits.com/symbol/NEULANDLAB.NSE">Neuland Laboratories</a> shares surged 20% ahead of the final dividend.&nbsp;<a href="https://stocktwits.com/symbol/AHLUCONT.NSE">Ahluwalia Contracts</a> ended 5% higher after securing a ₹2,089 crore order from DLF. Castrol shares finished 2% higher after favourable order on ₹4,131 crore tax dispute.&nbsp;Globally, European markets traded mixed on Trump's new tariff threats on the EU and Mexico, while US stock futures indicate a negative start on Wall Street.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

The Bombay Stock Exchange building is in Mumbai, India, on April 8, 2025. (Photo by Indranil Aditya/NurPhoto via Getty Images)

India Market Wrap: Nifty Ends Below 25,100 As Tech Stocks Stumble; Midcaps And Smallcaps Buck The Trend

The street turned cautious on tech ahead of HCL Tech's results, extending last week’s TCS-triggered selloff.

Equity

The street turned cautious on tech ahead of HCL Tech's results, extending last week’s TCS-triggered selloff.


Neuland&nbsp; Laboratories&nbsp;has staged an explosive breakout above the consolidation zone, with its shares rallying 15% on Monday.SEBI-registered&nbsp;<a href="https://stocktwits.com/VijayGuptaAdvisory">analyst Vijay Kumar Gupta</a> noted that the heavy volumes confirm institutional buying, adding that strong earnings and bullish sector sentiment back the rally.&nbsp;The trading volume has surged to 690.96K—the highest seen in several weeks. Technical indicators support this bullish move as the stock has broken decisively above the Ichimoku cloud. The Commodity Channel Index (CCI) stands at 307.91 (indicating overbought conditions but reflecting powerful breakout momentum), and On-Balance Volume (OBV) is spiking, confirming robust buying interest.&nbsp;Gupta identified support between ₹12,700–₹12,750, with resistance now at fresh all-time highs, which shows that a trend following move is in the play.&nbsp;Why Is Neuland Surging?<a href="https://stocktwits.com/symbol/NEULANDLAB.NSE">Neuland</a> reported a robust first-quarter (Q1 FY26) earnings with net profit surging 85% year-on-year (YoY), led by strong growth in the CMS (Custom Manufacturing Solutions) segment and better realization in niche APIs.&nbsp;In other recent developments, Neuland Labs announced a strategic multi-year contract with a leading US pharma player for peptide manufacturing, a high-margin segment.&nbsp;Foreign Institutional Investor (FII) holding has increased marginally in the latest shareholding pattern, which is a bullish signal for long-term investors. The broader sector is also benefiting from favorable trends, as CDMO/API players are being rerated due to China+1 tailwinds,&nbsp; improved pricing environment, and margin expansion opportunities.&nbsp;What To Watch&nbsp;&nbsp;Looking ahead, Gupta suggested watching for a follow-through move above ₹14,000 that could take the stock to ₹15,500–₹16,000 in the short-to-medium term. Continued consolidation above ₹13,000, supported by strong volume, is considered a healthy sign, while any dip in the CCI or Relative Strength Index (RSI) may present a dip-buying opportunity.&nbsp;He concluded that Neuland Labs is entering a high-growth, high-margin cycle with visibility from CMS contracts. Technically and fundamentally aligned breakout, which is ideal for momentum followers and growth investors.<stembedurl>https://stocktwits.com/VijayGuptaAdvisory/message/620824744</stembedurl>Retail sentiment has turned ‘bullish’ from ‘neutral’ last week on Stocktwits.<figure class="image"><img style="aspect-ratio:802/106;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_14_143515_png_a00c71f7f2.webp" alt="Screenshot 2025-07-14 143515.png" width="802" height="106"><figcaption>Neuland sentiment and message volume on July 14 as of 2:30 pm IST. | source: Stocktwits</figcaption></figure>Neuland shares have risen 3% year-to-date (YTD).For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Chartbuster Alert: Neuland Labs Soars Past Resistance On Bullish Technicals

The stock looks poised for a sustained rally with ₹15,500–₹16,000 in sight. The analyst sees growth visibility from CMS contracts and long-term upside from sector rerating. 

Two buzzing midcaps are in focus after strong chart setups and sharply diverging fundamentals drew retail attention ahead of the earnings season.SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/Vinaytaparia">Vinay Taparia</a> highlighted Neuland Laboratories and Netweb Technologies as technical breakout candidates.&nbsp;Neuland LaboratoriesFor&nbsp;<a href="https://stocktwits.com/symbol/NEULANDLAB.NSE/news">Neuland,</a> Taparia pointed to a bounce from an upward-moving trendline and a small breakout on Friday.&nbsp;<stembedurl>https://stocktwits.com/Vinaytaparia/message/620769926</stembedurl>He recommended buying at the current market price of ₹12,301 for targets of ₹14,000, ₹15,220, and ₹18,000, with a stop-loss on closing below ₹11,550.&nbsp;The time frame is one year.Netweb TechnologiesTaparia also noted a cup-and-handle breakout in&nbsp;<a href="https://stocktwits.com/symbol/NETWEB.NSE">Netweb Technologies</a>, accompanied by heavy volume.&nbsp;<stembedurl>https://stocktwits.com/Vinaytaparia/message/620770454</stembedurl>He suggested buying at ₹1,947 for targets of ₹2,080 and ₹2,350, with a closing stop-loss at ₹1,860 for a time frame between 6 months and 1 year.Netweb reported strong March quarter and full-year numbers for FY25. It also launched Skylus.ai, a GPU-based platform for AI infrastructure management.&nbsp;Chairman and MD Sanjay Lodha said FY25 marked the company’s highest-ever quarterly and annual income and profit after tax, backed by a strong order pipeline and growing AI adoption.&nbsp;The board has recommended a ₹2.5 per share final dividend, implying a 12.4% payout ratio, pending shareholder approval.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Double Breakout Alert: SEBI RA Flags Neuland, Netweb As High-Potential Midcaps

Neuland shares rose 10% on Monday, while Netweb impressed with record FY25 results.

India’s renewable energy, pharmaceutical, and infrastructure sectors are gaining investor attention heading into July, driven by structural growth drivers such as government incentives, global demand, and a stable policy environment.SEBI-registered analyst&nbsp;<a href="https://stocktwits.com/billiondreamz">Rohit Mehta</a> said smart money is rotating into these three sectors, driven by long-term fundamentals.&nbsp;<stembedurl>https://stocktwits.com/billiondreamz/message/619543180</stembedurl>In renewable energy, Mehta cited India’s ₹24,000 crore PLI scheme for solar modules, rising domestic installations toward the 175+ GW 2030 target, and global deals like Waaree Solar Americas’ 540 MW order.&nbsp;He flagged&nbsp;<a href="https://stocktwits.com/symbol/WAAREEENER.NSE">Waaree Energies</a>,&nbsp;<a href="https://stocktwits.com/symbol/INOXWIND.NSE">Inox Wind</a>,&nbsp;<a href="https://stocktwits.com/symbol/SERVOTECH.NSE">Servotech Power</a>, and&nbsp;<a href="https://stocktwits.com/symbol/KPIGREEN.NSE">KPI Green Energy</a> as key stocks to watch.In pharma, Mehta noted a shift from low-margin generics to high-value contract research and manufacturing services (CRAMS), contract development and manufacturing organizations (CDMO), and biosimilars, driven by the China+1 strategy and increased production-linked incentive (PLI) support.&nbsp;<a href="https://stocktwits.com/symbol/SUVEN.NSE">Suven Pharma</a>,&nbsp;<a href="https://stocktwits.com/symbol/DIVISLAB.NSE">Divi’s Labs</a>,&nbsp;<a href="https://stocktwits.com/symbol/BIOCON.NSE">Biocon</a>,&nbsp;<a href="https://stocktwits.com/symbol/NEULANDLAB.NSE">Neuland Labs</a>, and&nbsp;<a href="https://stocktwits.com/symbol/SYNGENE.NSE">Syngene</a> were highlighted for their strong positioning.On infrastructure, Mehta pointed to ₹11 lakh crore in capital expenditure plans in the FY26 Budget and continued momentum in railways, metros, defense, and electrification.&nbsp;He named&nbsp;<a href="https://stocktwits.com/symbol/LTTS.NSE">L&amp;T</a>,&nbsp;<a href="https://stocktwits.com/symbol/IRB.NSE">IRB Infra</a>,&nbsp;<a href="https://stocktwits.com/symbol/KEC.NSE">KEC International</a>,&nbsp;<a href="https://stocktwits.com/symbol/KNRCON.NSE">KNR Construction</a>,&nbsp;<a href="https://stocktwits.com/symbol/AHLUCONT.NSE">Ahluwalia Contracts</a>,&nbsp;<a href="https://stocktwits.com/symbol/POLYCAB.NSE">Polycab</a>, and&nbsp;<a href="https://stocktwits.com/symbol/KEI.NSE">KEI Industries</a> as top beneficiaries.For updates and corrections, email newsroom[at]stocktwits[dot]com.

July Stock Themes: SEBI RA Rohit Mehta Flags Renewables, Pharma, Infra Sectors For Big Rotations

India's clean energy push, pharma transformation, and record capex plans are drawing investor focus heading into July, with key beneficiaries emerging across all three sectors. 

Neuland Laboratories Ltd. engages in the manufacture and export of bulk pharmaceutical ingredients and intermediates for the generics industry. It also offers custom manufacturing solutions and synthetic peptides. The company was founded by Rama Mohan Rao Davuluri on January 7, 1984 and is headquartered in Hyderabad, India.

Current Price	16,100.00
Prev Close	16,285.00
Open	16,255.00
Dividend Yield	0.10%
50-Day Moving Average	16,528.22
Beta	0.15
Avg. Volume	78,600.89
PE Ratio	85.90

52-Week High	19,747.00
52-Week Low	10,190.70
Market Capitalization	208.23B
EPS (Annual)	202.74
Price to Book	12.73
Revenue Per Employee	8.1M
Enterprise Value/EBITDA	N/A

NEULANDLAB.NSE
Neuland Laboratories Ltd.

Feed

News

Sentiment

Fundamentals

Info

Latest NEULANDLAB.NSE News

NEULANDLAB.NSENeuland Laboratories Ltd.